Insulet
Founded Year
2000Stage
IPO | IPOTotal Raised
$119.5MDate of IPO
11/19/2007Market Cap
19.83BStock Price
286.20Missing: Insulet's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Insulet's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Insulet
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Insulet is included in 3 Expert Collections, including Diabetes.
Diabetes
1,903 items
Medical Devices
3,567 items
https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.
Biopharma Tech
260 items
Insulet Patents
Insulet has filed 197 patents.
The 3 most popular patent topics include:
- Drug delivery devices
- Medical equipment
- Insulin therapies
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
2/11/2020 | 1/10/2023 | Diabetes, Insulin therapies, Diets, Nutrition, Obesity | Grant |
Application Date | 2/11/2020 |
|---|---|
Grant Date | 1/10/2023 |
Title | |
Related Topics | Diabetes, Insulin therapies, Diets, Nutrition, Obesity |
Status | Grant |
Latest Insulet News
Jan 27, 2023
January 27, 2023 Insulet announced that it has emailed 29,000 Omnipod insulin pump customers to advise them that some of their personal health information (PHI) — but not financial, social security number, email or password — was inadvertently shared with Insulet’s website performance and marketing partners. Around Dec. 1, 2022, Insulet said it sent customers a Medical Device Correction (MDC) email which included a clickable URL response link for the customer to acknowledge receipt of the email. The link included the customer’s IP address, whether the customer is an Omnipod DASH insulin management system user and whether the customer has a personal diabetes manager. The company said the data exposure happened because the URLs “were shared with website performance and marketing partners of Insulet through website ‘cookies’ and/or other trackers embedded in the omnipod.com website code on the MDC acknowledgment web page.” Insulet said it discovered the issue on Dec. 6 and disabled the tracking codes so no further data would be exposed and requested that its partners delete their logs of IP addresses and URLs. — Karen Early
Insulet Frequently Asked Questions (FAQ)
When was Insulet founded?
Insulet was founded in 2000.
Where is Insulet's headquarters?
Insulet's headquarters is located at 9 Oak Park Drive, Bedford.
What is Insulet's latest funding round?
Insulet's latest funding round is IPO.
How much did Insulet raise?
Insulet raised a total of $119.5M.
Who are the investors of Insulet?
Investors of Insulet include Prism VentureWorks, SV Health Investors, Versant Ventures, Pequot Venture Capital, SightLine Partners and 14 more.
Who are Insulet's competitors?
Competitors of Insulet include MedicSen and 1 more.
Compare Insulet to Competitors
Hedia is a mobile application that aims to make life easier for those with diabetes. Hedia can calculate exactly how much insulin an individual needs based on their carbohydrate intake and activity level. The app subsequently remembers this data in order to keep track of how much active insulin remains in the body, meaning Hedia learns the user's insulin needs and habits over time.
DigiBete is a digital video platform to support self-care and virtual clinics for children and young people with diabetes. It was founded in 2016 and is based in Leeds, England.
Retinai supports eye care professionals and patients throughout the medical examination process using Artificial Intelligence. Its vision is to foster the transition from reactive medicine to preventive medicine for high-impact diseases such as age-related Macular Degeneration, Diabetic Retinopathy, and Glaucoma. Its solutions rely on advances in medical image analysis, opthalmology, and machine learning.
Suvera is a technology and virtual healthcare solution company. It aims to reduce the workload and waiting times at physical clinics by providing services virtually, such as administering prescriptions and tracking blood pressure results. It provides services remotely for patients with long-term chronic conditions like diabetes and hypertension. The company was founded in 2019 and is based in Spitalfields, U.K.
LetsGetChecked offers at-home tests for a variety of conditions. The company builds and delivers at-home testing kits, including hormone tests, fertility tests, HPV tests and wellness tests for cholesterol or diabetes. Its services includes manufacturing, logistics, lab analysis, clinician support, and prescription fulfillment. The company was founded in 2015 and is based in Dublin, Ireland.
Changing Health provides digital education and personalized coaching to help people with Type 2 diabetes control their symptoms using research to develop behavioral change techniques.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.